NeuBase Therapeutics (NBSE) Q4 2022 Earnings

Feb 14Confirmed
May 2022
Aug 2022
Dec 2022
Q4 2022
-0.3
-0.24
-0.19
-0.13

Details

Expected EPS
-0.2
Actual EPS
-0.13
Surprise EPS
0.07
Surprise Percent
+35%

Description

⁨NeuBase Therapeutics⁩ (⁦NBSE⁩) has reported earnings of ⁦-0.13⁩ per share for ⁦Q4 2022⁩.

0 Comments

Share your thoughts